CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.020
+0.073 (7.72%)
At close: Feb 13, 2026, 4:00 PM EST
1.000
-0.020 (-1.96%)
After-hours: Feb 13, 2026, 7:52 PM EST
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $11.77 million as of February 13, 2026. Its market cap has decreased by -60.16% in one year.
Market Cap
11.77M
Enterprise Value
9.91M
1-Year Change
-60.16%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $11.77M, a decrease of -74.48%. That is a compound annual growth rate of -38.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 11.77M | -23.60% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 12.63M |
| Kairos Pharma | 12.45M |
| GT Biopharma | 12.36M |
| BioCardia | 12.10M |
| KALA BIO | 11.48M |
| Sensei Biotherapeutics | 11.47M |
| Longeveron | 11.43M |
| BioAtla | 11.14M |